Ethyl 8-hydroxy-2-methylimidazo[1,2-a]pyridine-3-carboxylate, 95.0%, 5g

(S)-5-(2-Methyl-4-(oxetan-3-yl)piperazin-1-yl)pyridin-2-amine, 98%, 1g

Triphenylene>96.0%(GC)100mg

N-(3-Triethoxysilylpropyl)gluconamide, 30% in ethanol, 95%, 100g

N-(4-Chlorophenyl)-5,5-difluoro-1-(3-(furan-2-yl)benzoyl)piperidine-3-carboxamide, 98.0%, 50mg

rel-N-((1r,4r)-4-Hydroxycyclohexyl)acetamide, 98+%, 5g

alpha-Bromodiphenylmethane>97.0%(HPLC)(T)25g

[(2E)-3-(2-methoxyphenyl)prop-2-en-1-yl](propan-2-yl)amine hydrochloride, 95.0%, 1g

(S)-3-Amino-1-N-Cbz-pyrrolidine hydrochloride, 98.0%, 1g

(4-(Bis(4-(tert-butyl)phenyl)amino)phenyl)boronic acid, 97%, 100mg

7-Bromo[1,2,4]triazolo[1,5-a]pyridine, 95.0%, 1g

Dibenzothiophene>98.0%(GC)5g

Methyl 4-(2-aminoacetyl)benzoate hydrochloride, 97%, 10g